×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
NEW ICH INITIATIVES IN SAFETY TESTING
Session Chair(s)
Beatriz Silva Lima, PharmD, PhD
Director of FFUL, Faculty of Pharmacy
University of Lisbon, Portugal
This session will cover the non-clinical topics new initiatives to trigger the improvement of the nonclinical testing paradigms.
Speaker(s)
Revisiting the Carcinogenicity Testing Strategy (S1)
Jan Willem van der Laan, PhD
Medicines Evaluation Board, Netherlands
Senior Assessor Pharmacology and Toxicology
Linking Innovation and Regulatory Toxicology – a proposed ICH approach
Steven Spanhaak, MSc
Janssen Research & Development, Belgium
Scientific Director
Have an account?